Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Berger

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|August 12, 2004
A dramatic change in HIV treatmentKarl Wilkins, Toby Maurer, Timothy Berger
Archives of Dermatology|July 21, 2004
Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathyToby Maurer, Ann Poncelet, Timothy Berger
Journal of the American Academy of Dermatology|April 17, 2022
In reply: Counterpoint: Limited life expectancy, basal cell carcinoma, health care today, and unintended consequencesEleni Linos, Timothy Berger, Mary-Margaret Chren
Journal of the American Academy of Dermatology|June 20, 2015
Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life: The key role of the dermatologistEleni Linos, Timothy Berger, Mary-Margaret Chren
Journal of the American Academy of Dermatology|November 30, 2010
The eDerm online curriculum: a randomized study of effective skin cancer teaching to medical studentsJacqueline C Dolev, Patricia O'Sullivan, Timothy Berger
Archives of Dermatology|June 12, 2002
Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virusPatricia Nguyen, Kirsten Vin-Christian, Michael E Ming, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2014
Update on the immunological mechanism of action behind phototherapyDanielle Tartar, Tina Bhutani, Monica Huynh, et al.
International Journal of Women'S Dermatology|January 8, 2020
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD)Jodie Raffi, Raagini Suresh, Timothy Berger, et al.
Journal of the American Academy of Dermatology|July 23, 2013
Itch as a patient-reported symptom in ambulatory care visits in the United StatesMelissa Shive, Eleni Linos, Timothy Berger, et al.
JAAD Case Reports|August 11, 2018
Brachioradial pruritus treated with computed tomography-guided cervical nerve root block: A case seriesBrent D Weinberg, Matthew Amans, Sibel Deviren, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|August 12, 2004
A dramatic change in HIV treatmentKarl Wilkins, Toby Maurer, Timothy Berger
Archives of Dermatology|July 21, 2004
Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathyToby Maurer, Ann Poncelet, Timothy Berger
Journal of the American Academy of Dermatology|April 17, 2022
In reply: Counterpoint: Limited life expectancy, basal cell carcinoma, health care today, and unintended consequencesEleni Linos, Timothy Berger, Mary-Margaret Chren
Journal of the American Academy of Dermatology|June 20, 2015
Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life: The key role of the dermatologistEleni Linos, Timothy Berger, Mary-Margaret Chren
Journal of the American Academy of Dermatology|November 30, 2010
The eDerm online curriculum: a randomized study of effective skin cancer teaching to medical studentsJacqueline C Dolev, Patricia O'Sullivan, Timothy Berger
Archives of Dermatology|June 12, 2002
Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virusPatricia Nguyen, Kirsten Vin-Christian, Michael E Ming, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2014
Update on the immunological mechanism of action behind phototherapyDanielle Tartar, Tina Bhutani, Monica Huynh, et al.
International Journal of Women'S Dermatology|January 8, 2020
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD)Jodie Raffi, Raagini Suresh, Timothy Berger, et al.
Journal of the American Academy of Dermatology|July 23, 2013
Itch as a patient-reported symptom in ambulatory care visits in the United StatesMelissa Shive, Eleni Linos, Timothy Berger, et al.
JAAD Case Reports|August 11, 2018
Brachioradial pruritus treated with computed tomography-guided cervical nerve root block: A case seriesBrent D Weinberg, Matthew Amans, Sibel Deviren, et al.
Pageof 2